Histoplasma epiglottitis in a patient with Crohn's disease maintained on infliximab, prednisone, and azathioprine

Int J Infect Dis. 2013 Aug;17(8):e650-2. doi: 10.1016/j.ijid.2013.02.021. Epub 2013 Apr 15.

Abstract

Crohn's disease is associated with treatment and non-treatment infectious complications. Among the treatment-related infectious complications, Histoplasma infection is interesting because of significant overlap between its symptoms and Crohn's disease exacerbation. It is often mistaken as Crohn's disease exacerbation. We present a case of disseminated histoplasmosis presenting as Histoplasma epiglottitis in a patient with Crohn's disease maintained on infliximab, prednisone, and azathioprine.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects
  • Antibodies, Monoclonal / therapeutic use
  • Antifungal Agents / therapeutic use
  • Azathioprine / adverse effects
  • Azathioprine / therapeutic use
  • Crohn Disease / complications*
  • Crohn Disease / drug therapy
  • Drug Therapy, Combination
  • Epiglottitis / diagnosis
  • Epiglottitis / drug therapy
  • Epiglottitis / etiology*
  • Histoplasma*
  • Histoplasmosis / diagnosis
  • Histoplasmosis / drug therapy
  • Histoplasmosis / etiology*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / therapeutic use
  • Infliximab
  • Male
  • Prednisone / adverse effects
  • Prednisone / therapeutic use

Substances

  • Antibodies, Monoclonal
  • Antifungal Agents
  • Immunosuppressive Agents
  • Infliximab
  • Azathioprine
  • Prednisone